We are live on
!
Find out more
BP
Ballentine Partners Portfolio holdings
AUM
$8.18B
1-Year Est. Return
27.59%
This Fund
S&P 500
This Quarter
Est. Return
+6.79%
1 Year Est. Return
+27.59%
3 Year Est. Return
+76.88%
5 Year Est. Return
+72.28%
10 Year Est. Return
+235.36%
AUM
$815M
AUM Growth
+$71.6M
(+9.6%)
Cap. Flow
+$21.9M
Cap. Flow
% of AUM
2.68%
Top 10 Holdings %
Top 10 Hldgs %
64.64%
Holding
147
New
20
Increased
66
Reduced
21
Closed
11
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$18.5M |
| 2 |
Vanguard Total Stock Market ETF
VTI
|
+$3.5M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$1.91M |
| 4 |
Berkshire Hathaway Class A
BRK.A
|
+$1.56M |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$1.34M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$14.3M |
| 2 |
Vanguard Dividend Appreciation ETF
VIG
|
+$1.29M |
| 3 |
WisdomTree Emerging Markets High Dividend Fund
DEM
|
+$611K |
| 4 |
ATRS
Antares Pharma, Inc.
ATRS
|
+$499K |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$446K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 4.05% |
| 2 | Technology | 1.18% |
| 3 | Industrials | 0.94% |
| 4 | Healthcare | 0.91% |
| 5 | Consumer Staples | 0.59% |
Similar funds
LGF
OC
CCM
CL
WJWM
CLOS
WA
CCM
Ballentine Partners's Q3 2013 Portfolio in Review
As of Q3 2013, Ballentine Partners held 147 positions worth $815M, up 9.6% from $744M the previous quarter. Its ten largest holdings account for 65% of the portfolio.
Ballentine Partners's Q3 2013 filing shows 20 new, 66 increased, 21 reduced and 11 closed positions. Its largest new stake was iShares Core MSCI EAFE ETF: 19,175 shares worth $1.1M. The largest sale was Vanguard FTSE Emerging Markets ETF, an estimated $14.3M.
By sector, the portfolio is most concentrated in Financials at 4.1% of assets, up from 4% a quarter earlier, followed by Technology and Industrials.
- Ballentine Partners's largest Q3 2013 buy was iShares Core MSCI EAFE ETF: 19,175 shares worth $1.1M.
- Ballentine Partners added most to iShares Core MSCI Emerging Markets ETF in Q3 2013, an estimated $18.5M increase.
- Ballentine Partners's biggest Q3 2013 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $14.3M.
- Ballentine Partners fully exited Antares Pharma, Inc. in Q3 2013, selling an estimated $499K.
- Ballentine Partners's ten largest holdings make up 65% of its $815M portfolio in Q3 2013.
- Ballentine Partners opened 20 new positions and closed 11 in Q3 2013.
- Ballentine Partners's portfolio value rose 9.6% quarter-over-quarter to $815M.
Based on Ballentine Partners's 13F filing for Q3 2013, filed 29 Oct 2013.